Hemoglobin-based oxygen carriers as resuscitative solutions for trauma and combat casualty care1

Blood Substitutes

Volumn , Issue , 2006, Pages 139-151

  Kramer, George C ^a   Nascimento, Paulo ^b   Vaid, Sumreen U ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67349134386     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012759760-7/50019-6     Document Type: Chapter

References (70)

1. Bentley T.B., Tabaku L.S., Handrigan M.T., et al. Prolonged permissive hypotensive resuscitation in an awake rat model of hemorrhagic shock. Fed. Am. Soc. Exper. Biol. J. 2003, 17:A806.18.
2. Bickell W.H., Matthew J., Wall M.J., et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N. Engl. J. Med. 1994, 331:1105-1109.
3. Brauer K.I., Prough D.S., Traber D.L., et al. Large volume infusion of lactated Ringer's (LR) exacerbates hemoglobin (DCLHb) induced hypertension. Am. J. Resp. Crit. Care Med. 1999, 159:A521.
4. Brauer K.I., Prough D.S., Traber D.L., Kramer G.C. Lactated Ringer's solution (LR) exacerbates increased minute cardiac work after diaspirin crosslinked hemoglobin (DCLHb). Shock 1999, 11:67.
5. Buehler P.W., Alayash A.I. Toxicities of hemoglobin solutions: in search of in-vitro and in-vivo model systems. Transfusion 2004, 44:1516-1530.
6. Capone A., Safar P., Stezoki W., et al. Improved outcome with fluid restriction in treatment of uncontrolled hemorrhagic shock. J. Am. Coll. Surg. 1995, 180:269-276.
7. Creteur J., Vincent J.L. Hemoglobin solutions. Crit. Care Med. 2003, 31:S698-S707.
8. Driessen B., Jahr J.S., Lurie F., et al. Effects of hemoglobin-based oxygen carrier Hemoglobin glutamer-200 (bovine) on intestinal perfusion and oxygenation in a canine hypovolemia model. Br. J. Anaesthesia 2001, 86:683-692.
9. Drobin D., Hahn R.G. Volume kinetics of Ringer's solution in hypovolemic volunteers. Anesthesiology 1999, 90:81-91.
10. Drobin D., Kjellstrom B.T., Malm E., et al. Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4). J. Appl. Physiol. 2004, 96:1843-1853.
11. Dubick M.A., Sondeen J.L., Prince M.D., et al. Hypotensive resuscitation with Hextend, Hespan or PolyHeme in a swine hemorrhage model. Shock 2004, 21:42.
12. Dutton R.P., Mackenzie C.F., Scalea T.M. Hypotentive resuscitation during active hemorrhage: impact on in-hospital mortality. J. Trauma 2002, 53(6):1196-1197. Comment in, author reply 1197-1198; PMID: 12478055; Comment in J. Trauma, 53(6), 1196; author reply 1196; PMID: 12478054; J. Trauma Inj. Inf. Crit. Care, 52, 1141-1146.
13. Fischer S.F., Burnet M., Traber D.L., et al. Plasma volume expansion with solutions of hemoglobin, albumin and Ringer lactate in sheep. Am. J. Physiol. 1999, 276:H2194-H2203.
14. Garrioch M.A., McClure J.H., Wildsmith J.A. Haemodynamic effects of diaspirin cross-linked hemoglobin (DCLHb) given before abdominal aortic aneurysm surgery. Br. J. Anaesth. 1999, 83:702-707.
15. Gibson J.B., Maxwell R.A., Schweitzer J.B., et al. Resuscitation from severe hemorrhagic shock after traumatic brain injury using saline, shed blood, or a blood substitute. Shock 2002, 17:234-244.
16. Gould S.A., Moore E.E., Hoyt D.B., et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J. Am. Coll. Surg. 1998, 187:113-122.
17. Gould S.A., Moore E.E., Hoyt D.B., et al. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J. Am. Coll. Surg. 2002, 195:445-455.
18. Greenberg A.G. Clinical implications of blood substitutes. Artif. Organs 1998, 22:47-49.
19. Handrigan, M., Bentley, T., Oliver, J. et al. (in press). Choice of fluid influences outcome in prolonged hypotensive resuscitation after hemorrhage in awake rats. Shock (in press, 2005).
20. Hartman J.C., Argoudelis G., Doherty D., et al. Reduced nitric oxide reactivity of a new recombinant human hemoglobin attenuates gastric dysmotility. Eur. J. Pharmacol. 1998, 363:175-178.
21. Hint H. Relationships between the chemical and physiochemical properties of dextran and its pharmacological effects. Dextrans: Current Concepts of Basic Actions and Clinical Applications 1971, 3-26. Charles C. Thomas, Springfield. J.R. Derrick, M.M. Guest (Eds.).
22. Hughes G.S., Yancey E.P., Albrecht R., et al. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans. Clin. Pharmacol. Therapeut. 1995, 58:434-443.
23. Intaglietta M. Microcirculatory basis for the design of artificial blood. Microcirculation 1999, 6:247-258.
24. Kasper S.M., Grune F., Walter M., et al. The effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth. Analg. 1998, 87:284-291.
25. Kerner T., Ahlers O., Veit S., et al. DCL-Hb for trauma patients with severe hemorrhagic shock: the European 'On-Scene' multicenter study. Intens. Care Med. 2003, 29:378-385.
26. Konrad C., Markl T., Schuepfer G., et al. The effects of in vitro hemodilution with gelatin, hydroxyethyl starch, and lactated Ringer's solution on markers of coagulation: an analysis using SONOCLOT. Anesth. Analg. 1999, 88:483-488.
27. Kramer G.C. Counterintuitive red blood cell substitute-polyethylene glycol-modified human hemoglobin. Crit. Care Med. 2003, 31:1882-1884.
28. Kramer G.C., Elgjo G.I., Poli de Figueiredo L.F., Wade C.E. Hyperosmotic-hyperoncotic solutions. Baillière's Clin Anaesthesiol. 1997, 11:143-146.
29. Kramer G.C., Poli de Figueiredo L.F. New blood substitutes: physiology and clinical impact. Prob. Anesth. 1999, 11:471-482.
30. Krieter H., Hagen G., Waschke K.F., et al. Isovolemic hemodilution with a bovine hemoglobin-based oxygen carrier: effects on hemodynamics and oxygen transport in comparison with a non-oxygen-carrying volume substitute. J. Cardiovasc. Anesth. 1997, 11:3-9.
31. Lamke L.-O., Liljedahl S.-O. Plasma volume changes after infusion of various plasma expanders. Resuscitation 1976, 5:93-102.
32. Levy J.H., Goodnough L.T., Greilich P.E., et al. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J. Thorac. Cardiovasc. Surg. 2002, 124:35-42.
33. Lurie F., Jahr J.S., Driessen B. Changes in circulating blood and plasma volume after hemoglobin-based oxygen carrier infusion and additional infusion of colloid solutions. Am. J. Therapeut. 2002, 9:425-430.
34. Mabry R.L., Holcomb J.B., Baker A.M., et al. United States Army Rangers in Somalia: an analysis of combat casualties on an urban battlefield. J. Trauma 2000, 49:515-528.
35. Malhotra A.K., Kelly M.E., Miller P.R., et al. Resuscitation with a novel hemoglobin-based oxygen carrier in a swine model of uncontrolled perioperative hemorrhage. Trauma 2003, 54:915-924.
36. Maxwell R.A., Gibson J.B., Fabian T.C., Proctor K.G. Resuscitation of severe chest trauma with four different hemoglobin-based oxygen-carrying solutions. J. Trauma Inj. Inf. Crit. Care 2000, 49:200-211.
37. McCarthy M.R., Vandegriff K.D., Winslow R.M. The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers. Biophys. Chem. 2001, 92:103-117.
38. McNeil C.J., Smith L.D., Jenkins L.D., et al. Hypotensive resuscitation using a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) leads to reversal of anaerobic metabolism. J. Trauma Inj. Inf. Crit. Care 2001, 50:1063-1075.
39. Michell M.W., Rafie A.D., Shah A., et al. Hypotensive and normotensive resuscitation of hemorrhagic shock with hextend or lactated ringer's (LR). Crit. Care Med. 2003, 31:A41.
40. Morales D., Madigan J., Cullinane S., et al. Reversal by vasopression of intractable hypotension in the late phase of hemorrhagic shock. Circulation 1999, 100:226-229.
41. Muir W.W., de Morais H.S., Constable P.D. The effects of a hemoglobin-based oxygen carrier (HBOC-301) on left ventricular systolic function in anesthetized dogs. Vet. Surg. 2000, 29:449-455.
42. Nolte D., Steinhauser P., Pickelmann S., et al. Effects of diaspirin-crosslinked hemoglobin (DCLHb) on local tissue oxygen tension in striated skin muscle: an efficacy study in the hamster. J. Lab. Clin. Med. 1997, 130:328-338.
43. Nucci M.L., Abuchowski A. The search for blood substitutes. Sci. Am. 1998, 278:72-77.
44. Pickelmann S., Nolte D., Messmer K. Diaspirin crosslinked hemoglobin (DCLHb) improves tissue oxygen tension in striated muscle of the hamster after ischemia/reperfusion. Intl J. Microcirc. Clin. Exp. 1996, 16:185.
45. Poli de Figueiredo L.F., Elgio G.I., Mathru M., et al. Hypertonic acetate-alpha-alpha hemoglobin for small volume resuscitation of hemorrhagic shock. Artif. Cells Blood Subst. Immob. Biotech. 1997, 25:61-73.
46. Poli de Figueiredo L.F., Cruz R.J., Neto A.C., et al. Initial management of severe hemorrhage with an oxygen-carrying hypertonic saline solution. Artif. Organs 2001, 25:922-927.
47. Rafie A.D., Rath P.A., Michell M.W., et al. Hypotensive resuscitation of multiple hemorrhages using crystalloid and colloids. Shock 2004, 22:262-269.
48. Sakurai M., Tanaka H., Matsuda T., et al. Reduced resuscitation fluid volume for second-degree experimental. J. Surg. Res. 1997, 73:24-27.
49. Sampson J.B., Davis M.R., Mueller D.L., et al. A comparison of the hemoglobin-based oxygen carrier HBOC-201 to other low-volume resuscitation fluids in a model of controlled hemorrhagic shock. J. Trauma Inj. Inf. Crit. Care 2003, 55:747-754.
50. Sanui M., Cohn S.M., King D.R., et al. A role for vasopressin during resuscitation of traumatic shock. A Role for Vasopressin During Resuscitation of Traumatic Shock 2004, 1-16. NATO, Brussels.
51. Sloan E.P., Koenigsberg M., Gens D., et al. Diaspirin crosslinked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. J. Am. Med. Assoc. 1999, 282:1857-1864.
52. Sloan E.P., Koenigsberg M.D. The efficacy trial of diaspirin crosslinked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock. Acad. Emerg. Med. 1999, 6:379-380.
53. Sondeen J.L., Dubick M.A., Prince M.D., et al. Prolonged hypotensive resuscitation with lactated Ringers solution (LR), Hextend, or hemoglobin-based oxygen carrier (HBOC) in a conscious, sedated hemorrhage model. Shock 2004, 21:25.
54. Standl T., Wilhelm S., Horn E.P., et al. Preoperative hemodilution with bovine hemoglobin. Acute hemodynamic effects in liver surgery patients. Anaesthesist 1997, 46:763-770.
55. Stern S.A. Low-volume fluid resuscitation for presumed hemorrhagic shock: helpful or harmful?. Curr. Opin. Crit. Care 2001, 7:422-430.
56. Stern S.A., Dronen S.C., Birrer P., Wang X. Effect of blood pressure on hemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury. Ann. Emerg. Med. 1993, 22:155-163.
57. Till G.O., Guilds L.S., Mahrougui M., et al. Role of xanthine oxidase in thermal injury of skin. Am. J. Pathol. 1989, 135:195-202.
58. Tølløfsrud S., Elgjo G.I., Prough D.S., et al. The dynamics of vascular volume and fluid shifts of infused lactated Ringer's and hypertonic saline dextran (HSD) in normovolemic sheep. Anesth. Analg. 2001, 93:823-831.
59. Tsai A.G., Intaglietta M. The unusual properties of effective blood substitutes. Keio J. Med. 2002, 51:17-20.
60. Tsai A.G., Friesenecker B., McCarthy M., et al. Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skinfold model. Am. J. Physiol. 1998, 275:H2170-H2180.
61. Vaid S.U., Shah A., Michell M.W., et al. Hemodynamic and metabolic consequences of hypotensive resuscitation using 3.0% NaCl. Shock 2003, 19:A58.
62. Vandegriff K.D., Winslow R.M. A theoretical analysis of oxygen transport: a new strategy for the design of hemoglobin-based red cell substitutes. Blood Substitutes: Physiological Basis of Efficacy 1995, 143-154. Birkhäuser, Boston. R.M. Winslow, K.D. Vandegriff, M. Intaglietta (Eds.).
63. Vandegriff K.D., Rohlfs R.J., Winslow R.M. Colloid osmotic effects of hemoglobin-based oxygen carriers. Advances in Blood Substitutes: Industrial Opportunities and Medical Challenges 1997, Vol. 3:207-232. Birkhäuser, Boston. R.M. Winslow, K.D. Vandegriff, M. Intaglietta (Eds.).
64. Vane L.A., Funston J.S., Deyo D.J., et al. Comparison of transfusion using packed red blood cells (PRBC) and hemoglobin based oxygen carriers (HBOC). Anesth. Analg. 2000, 90:S145-S146.
65. Vane L.A., Funston J.S., Kirschner R., et al. Comparison of transfusion with DCLHb or pRBCs for treatment of intraoperative anemia in sheep. J. Appl. Physiol. 2002, 92:343-353.
66. Wettstein R., Tsai A.G., Erni D., et al. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Crit. Care Med. 2003, 31:1824-1830.
67. Winslow R.M. The Regents of the University of California, US Patent 6,054,427 2000.
68. Wirk S., Vaslef S.N. Oxygen transport dynamics after resuscitation with a conjugated hemoglobin solution. Arch. Surg. 2004, 139:55-60.
69. Xianren W., Stezoski J., Safar P., Tisherman S.A. During prolonged (6h) uncontrolled hemorrhagic shock (UHS) with hypotensive fluid resuscitation, mean arterial pressure (MAP) must be maintained above 60-70 mmHg in rats. Crit. Care Med. 2003, 31:A40.
70. York G., Eggers J., Smith D., et al. Low-volume resuscitation with a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) provides adequate tissue oxygenation for survival in a porcine model of controlled hemorrhage. J. Trauma 2003, 55:873-885.